Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Videos

Maia Kayal
Conference Coverage
Maia Kayal, MD, on Interleukin-23s in IBD
09/30/2022
Dr Kayal discusses her presentation at the AIBD regional meeting on the efficacy and safety of IL-23 inhibitors in the treatment of inflammatory bowel disease.
Dr Kayal discusses her presentation at the AIBD regional meeting on the efficacy and safety of IL-23 inhibitors in the treatment of inflammatory bowel disease.
Dr Kayal discusses her...
09/30/2022
Advances in Inflammatory Bowel Disease Network
Aline Charabaty
Video
Aline Charabaty, MD, Welcomes You to the AIBD Virtual Regional Meeting
09/30/2022
Dr Charabaty previews the speakers and topics for the September 30 virtual regional meeting of Advances in Inflammatory Bowel Disease.
Dr Charabaty previews the speakers and topics for the September 30 virtual regional meeting of Advances in Inflammatory Bowel Disease.
Dr Charabaty previews the...
09/30/2022
Advances in Inflammatory Bowel Disease Network

Advertisement

Christina Ha
Conference Coverage
Christina Ha, MD, on Positioning Therapies for Ulcerative Colitis
09/30/2022
Dr Ha reviews the key takeaways from her presentation at the Advances in Inflammatory Bowel Diseases regional meeting on choosing and positioning therapies for ulcerative colitis.
Dr Ha reviews the key takeaways from her presentation at the Advances in Inflammatory Bowel Diseases regional meeting on choosing and positioning therapies for ulcerative colitis.
Dr Ha reviews the key takeaways...
09/30/2022
Advances in Inflammatory Bowel Disease Network
Florian Rieder
Conference Coverage
Florian Rieder, MD, on Extraintestinal Manifestations of IBD
08/29/2022
Dr Rieder, from Cleveland Clinic, reviews his presentation from the Advances in Inflammatory Bowel Diseases virtual regional meeting on August 27 on the extraintestinal manifestations of IBD.
Dr Rieder, from Cleveland Clinic, reviews his presentation from the Advances in Inflammatory Bowel Diseases virtual regional meeting on August 27 on the extraintestinal manifestations of IBD.
Dr Rieder, from Cleveland...
08/29/2022
Advances in Inflammatory Bowel Disease Network
Florian Rieder
Conference Coverage
Florian Rieder, MD, on Anti-TNF Biosimilars for IBD
08/27/2022
Dr Rieder reviews his presentation from the AIBD virtual regional meeting on August 27 on biosimilars for anti-tumor necrosis factor therapies, including ways to overcome the "nocebo effect" among patients.
Dr Rieder reviews his presentation from the AIBD virtual regional meeting on August 27 on biosimilars for anti-tumor necrosis factor therapies, including ways to overcome the "nocebo effect" among patients.
Dr Rieder reviews his...
08/27/2022
Advances in Inflammatory Bowel Disease Network

Advertisement

Kerri Glassner
Conference Coverage
Kerri Glassner, DO, on Leukocyte Trafficking
08/27/2022
Dr Glassner discusses her presentation at the Advances in Inflammatory Bowel Diseases virtual regional meeting August 27 on the role of leukocyte trafficking in inflammatory bowel disease.
Dr Glassner discusses her presentation at the Advances in Inflammatory Bowel Diseases virtual regional meeting August 27 on the role of leukocyte trafficking in inflammatory bowel disease.
Dr Glassner discusses her...
08/27/2022
Advances in Inflammatory Bowel Disease Network
Malcolm Irani
Conference Coverage
Malcolm Irani, MD, on Positioning Therapies for IBD
08/27/2022
Dr Irani, from Houston Methodist Academic Institute-Weill Cornell, reviews his presentation at the virtual AIBD regional meeting August 27 on positioning various therapies for inflammatory bowel diseases.
Dr Irani, from Houston Methodist Academic Institute-Weill Cornell, reviews his presentation at the virtual AIBD regional meeting August 27 on positioning various therapies for inflammatory bowel diseases.
Dr Irani, from Houston Methodist...
08/27/2022
Advances in Inflammatory Bowel Disease Network
Bincy Abraham
Conference Coverage
Bincy Abraham, MD, on Treatment Goals and Strategies in IBD
08/27/2022
Dr Abraham, chair of the virtual Advances in Inflammatory Bowel Diseases regional meeting on August 27, reviews her presentation on setting treatment goals and appropriate strategies for meeting them when treating patients with IBD.
Dr Abraham, chair of the virtual Advances in Inflammatory Bowel Diseases regional meeting on August 27, reviews her presentation on setting treatment goals and appropriate strategies for meeting them when treating patients with IBD.
Dr Abraham, chair of the virtual...
08/27/2022
Advances in Inflammatory Bowel Disease Network

Advertisement

Bincy Abraham
Conference Coverage
Bincy Abraham, MD, Welcomes You to AIBD!
08/26/2022
Dr Abraham, chair of the Advances in Inflammatory Bowel Diseases virtual regional meeting on August 27, reviews some of the topics and speakers to be featured at the meeting.
Dr Abraham, chair of the Advances in Inflammatory Bowel Diseases virtual regional meeting on August 27, reviews some of the topics and speakers to be featured at the meeting.
Dr Abraham, chair of the...
08/26/2022
Advances in Inflammatory Bowel Disease Network
Miguel Regueiro MD
Conference Coverage
Miguel Regueiro, MD, on Positioning Therapies for IBD
07/25/2022
Dr Regueiro, chief of the Digestive Disease and Surgery Institute at Cleveland Clinic, discusses his presentation at the Advances in Inflammatory Bowel Diseases regional meeting on positioning and sequencing therapies for Crohn disease and...
Dr Regueiro, chief of the Digestive Disease and Surgery Institute at Cleveland Clinic, discusses his presentation at the Advances in Inflammatory Bowel Diseases regional meeting on positioning and sequencing therapies for Crohn disease and...
Dr Regueiro, chief of the...
07/25/2022
Advances in Inflammatory Bowel Disease Network

Advertisement

Advertisement

Advertisement

Latest News

News
Lupus and IBD Share Microbiome Features
10/18/2024
Researchers identified distinct microbial signatures with significant overlaps between systemic lupus erythematosus and inflammatory bowel disease.
Researchers identified distinct microbial signatures with significant overlaps between systemic lupus erythematosus and inflammatory bowel disease.
Researchers identified distinct...
10/18/2024
Advances in Inflammatory Bowel Disease Network
News
Standard Dosing of Infliximab Effective for Steroid-Refractory ASUC
10/18/2024
While infliximab proved safe and effective for inducing remission in acute severe ulcerative colitis, higher doses and varied induction strategies showed no significant change in response.
While infliximab proved safe and effective for inducing remission in acute severe ulcerative colitis, higher doses and varied induction strategies showed no significant change in response.
While infliximab proved safe and...
10/18/2024
Advances in Inflammatory Bowel Disease Network
News
The Risks of Placebo in IBD Drug Trials
10/18/2024
Investigators recommend alternative trial designs to reduce potential harms to placebo-receiving patients with inflammatory bowel disease.
Investigators recommend alternative trial designs to reduce potential harms to placebo-receiving patients with inflammatory bowel disease.
Investigators recommend...
10/18/2024
Advances in Inflammatory Bowel Disease Network
News
Endoscopic Healing Index Shows Limited Utility for Identifying CD Remission
10/08/2024
Researchers at the University of Chicago recommend using the EHI with another modality to accurately identify inflammation among patients with Crohn’s disease.
Researchers at the University of Chicago recommend using the EHI with another modality to accurately identify inflammation among patients with Crohn’s disease.
Researchers at the University of...
10/08/2024
Advances in Inflammatory Bowel Disease Network
News
Scores Predict Corticosteroid Failure Risk in Patients With ASUC
10/03/2024
Risk of rescue scores that include several clinical, laboratory, and endoscopic variables may help improve outcomes in patients with acute severe ulcerative colitis.
Risk of rescue scores that include several clinical, laboratory, and endoscopic variables may help improve outcomes in patients with acute severe ulcerative colitis.
Risk of rescue scores that...
10/03/2024
Advances in Inflammatory Bowel Disease Network
News
Previous Stricturing Increases Risk of Anastomotic Stricture in Postoperative CD
10/01/2024

Jolynn Tumolo

Jolynn Tumolo
Early detection and treatment are the keys to reducing risk of progressive disease.
Early detection and treatment are the keys to reducing risk of progressive disease.
Early detection and treatment...
10/01/2024
Advances in Inflammatory Bowel Disease Network
News
Ustekinumab Shows Superior Persistence in CD Patients With Prior Biologic Use
09/30/2024
When used after a first-line agent, ustekinumab had significantly better persistence than other biologics.
When used after a first-line agent, ustekinumab had significantly better persistence than other biologics.
When used after a first-line...
09/30/2024
Advances in Inflammatory Bowel Disease Network
News
Upadacitinib Shows Efficacy Among Biologic-Exposed Patients With Crohn’s Disease
09/24/2024
A recent study revealed upadacitinib significantly improved clinical and endoscopic outcomes, even among patients with prior biologic failure.
A recent study revealed upadacitinib significantly improved clinical and endoscopic outcomes, even among patients with prior biologic failure.
A recent study revealed...
09/24/2024
Advances in Inflammatory Bowel Disease Network
FDA alert
FDA Alert
FDA Approves Guselkumab for Moderate to Severe Ulcerative Colitis
09/12/2024
Johnson & Johnson’s guselkumab is the first and only fully-human, dual-acting monoclonal antibody that blocks IL-23 and binds to CD64.
Johnson & Johnson’s guselkumab is the first and only fully-human, dual-acting monoclonal antibody that blocks IL-23 and binds to CD64.
Johnson & Johnson’s guselkumab...
09/12/2024
Advances in Inflammatory Bowel Disease Network
News
Upadacitinib Provides Rapid Response in Crohn's Disease
08/29/2024
Pooled data from induction trials showed improvement in symptoms of Crohn’s disease within a week.
Pooled data from induction trials showed improvement in symptoms of Crohn’s disease within a week.
Pooled data from induction...
08/29/2024
Advances in Inflammatory Bowel Disease Network

Advertisement

Advertisement

Advertisement

Latest Podcasts

Freddy Caldera
Podcast
Freddy Caldera, DO, on the RSV Vaccine for Patients With IBD
10/11/2024
Dr Caldera, from the University of Wisconsin School of Medicine, provides an overview of the risks of respiratory syncytial virus to older adults, including patients with IBD, and the importance of ensuring patients receive this vaccine along...
Dr Caldera, from the University of Wisconsin School of Medicine, provides an overview of the risks of respiratory syncytial virus to older adults, including patients with IBD, and the importance of ensuring patients receive this vaccine along...
Dr Caldera, from the University...
10/11/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Updates on the PIANO Study of IBD and Pregnancy
10/07/2024
IBD Drive Time Hosts Millie Long, MD, and Raymond Cross, MD, discuss new recommendations for managing inflammatory bowel disease among pregnant patients or those wanting to conceive, resulting from updates to the landmark PIANO study. 
IBD Drive Time Hosts Millie Long, MD, and Raymond Cross, MD, discuss new recommendations for managing inflammatory bowel disease among pregnant patients or those wanting to conceive, resulting from updates to the landmark PIANO study. 
IBD Drive Time Hosts Millie...
10/07/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: David Hudesman, MD, on Work Productivity in IBD
09/19/2024
Dr David Hudesman of NYU-Langone Health joins IBD Drive Time host Dr Raymond Cross to talk about how inflammatory bowel disease affects work productivity and social activities.
Dr David Hudesman of NYU-Langone Health joins IBD Drive Time host Dr Raymond Cross to talk about how inflammatory bowel disease affects work productivity and social activities.
Dr David Hudesman of NYU-Langone...
09/19/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Erin Forster, MD, on Risankizumab for Ulcerative Colitis
09/03/2024
Dr Erin Forster of the Medical University of South Carolina joins IBD Drive Time hosts Dr Millie Long and Dr Raymond Cross to review results of the trials for risankizumab in ulcerative colitis and discuss its positioning in treatment.
Dr Erin Forster of the Medical University of South Carolina joins IBD Drive Time hosts Dr Millie Long and Dr Raymond Cross to review results of the trials for risankizumab in ulcerative colitis and discuss its positioning in treatment.
Dr Erin Forster of the Medical...
09/03/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Jordan Axelrad, MD, on IBD and Malignancy
08/19/2024
Dr Jordan Axelrad and host Dr Raymond Cross discuss the considerations for IBD treatment among patients with history of or a newly-diagnosed malignancy, including when to switch IBD treatments, the importance of controlling disease, and how...
Dr Jordan Axelrad and host Dr Raymond Cross discuss the considerations for IBD treatment among patients with history of or a newly-diagnosed malignancy, including when to switch IBD treatments, the importance of controlling disease, and how...
Dr Jordan Axelrad and host Dr...
08/19/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Dr Jana Al Hashash on Diet and Nutrition in IBD Care
08/05/2024
Dr Jana Al Hashash from Mayo Clinic—Florida offers guidance on how diet can affect IBD and the best approaches to maintaining adequate nutrition, along with hosts Millie Long, MD, and Raymond Cross, MD.
Dr Jana Al Hashash from Mayo Clinic—Florida offers guidance on how diet can affect IBD and the best approaches to maintaining adequate nutrition, along with hosts Millie Long, MD, and Raymond Cross, MD.
Dr Jana Al Hashash from Mayo...
08/05/2024
Advances in Inflammatory Bowel Disease Network
Shubha Bhat
Podcast
Shubha Bhat, PharmD, on the Role of the Clinical Pharmacist in IBD
07/25/2024
Dr Bhat reports on the recent systematic review and RAND consensus process to define the role of the clinical pharmacist in caring for patients with inflammatory bowel disease.
Dr Bhat reports on the recent systematic review and RAND consensus process to define the role of the clinical pharmacist in caring for patients with inflammatory bowel disease.
Dr Bhat reports on the recent...
07/25/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: The Best of DDW, Part 2
07/18/2024
In part 2 of this podcast, cohost Dr Millie Long discusses her picks for the "Best of DDW" on inflammatory bowel disease with her cohost, Dr Ray Cross.
In part 2 of this podcast, cohost Dr Millie Long discusses her picks for the "Best of DDW" on inflammatory bowel disease with her cohost, Dr Ray Cross.
In part 2 of this podcast,...
07/18/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Best of DDW, Part 1
07/09/2024
In the first episode of this two-part series, Dr Raymond Cross of Mercy Medical Center reviews his top picks for the best abstracts on inflammatory bowel disease presented at this year's Digestive Disease Week with cohost Dr Millie Long of...
In the first episode of this two-part series, Dr Raymond Cross of Mercy Medical Center reviews his top picks for the best abstracts on inflammatory bowel disease presented at this year's Digestive Disease Week with cohost Dr Millie Long of...
In the first episode of this...
07/09/2024
Advances in Inflammatory Bowel Disease Network
Millie Long
Video
Millie Long, MD, on Comparative Effectiveness in Ulcerative Colitis
06/24/2024
Dr Long reviews her presentation from the AIBD regional meeting on using comparative effectiveness data to choose from among the growing number of therapies for treating ulcerative colitis.
Dr Long reviews her presentation from the AIBD regional meeting on using comparative effectiveness data to choose from among the growing number of therapies for treating ulcerative colitis.
Dr Long reviews her presentation...
06/24/2024
Advances in Inflammatory Bowel Disease Network

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use